Renovare Environmental Inc Ordinary Shares RENO 深 滬
等待開盤 10-27 09:30:00 美东时间
0.1721
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.1721
- 總市值 605.78万
- 52周最高 1.85
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.169
- 委 比 0.00%
- 總股本 3519.95万
- 歷史最高 5.76
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.169
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dragonfly Energy Says United States Patent And Trademark Office Issues Notice Of Allowance For Company's IntelLigence Battery Communication Technology
RENO, Nev., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and maker of Battle Born Batteries®, today
10-15 19:38
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
<p>RenovoRx, Inc. 宣布聘请著名介入肿瘤学家 Thierry de Baère 教授加入其科学顾问委员会。De Baère 教授在局部区域癌症治疗领域拥有丰富经验，其专长与 RenovoRx 的 TAMP™ 技术平台高度契合。TAMP 技术通过 RenovoCath 设备实现靶向药物递送，旨在优化肿瘤治疗效果并减少系统毒性。RenovoRx 正在推进 TAMP 技术的临床试验，并致力于将其应用于更多商业机会。</p>
10-09 12:30
i-80 Gold Receives Construction Permits and Initiates Underground Development at Archimedes
RENO, Nev., Sept. 5, 2025 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold", or the "Company") announces that it has received all required permits and commenced co...
09-05 19:41
Dragonfly Energy Secures U.S. Patent For Wakespeed Charge Control, Advancing Towing Vehicle-To-Trailer Battery Charging Technology
Secures new U.S. patent protecting Wakespeed® Charge Control technology for high-power vehicle-to-trailer chargingReinforces the competitive position of Dragonfly Energy's intellectual property portfolio of ~100
09-04 19:36
POLARIS RZR PRO R FACTORY REIGNS SUPREME AT 2025 VEGAS TO RENO
Polaris-Supported Racer Mitch Guthrie Jr. and his RZR Pro R Factory Win UTV Overall MINNEAPOLIS, Aug. 18, 2025 /PRNewswire/ -- In a stunning display of skill, stamina, and precision, Polaris...
08-19 07:55
RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire
<p>RenovoRx expands its commercial presence with 13 cancer centers approved to purchase RenovoCath, including 4 repeat customers. The company hires Philip Stocton as Senior Director of Sales, leveraging his 25+ years in MedTech and interventional oncology. This growth underscores the demand for localized tumor treatments beyond traditional IV chemotherapy. RenovoCath's adoption highlights its potential to improve patient outcomes by reducing syst...
08-06 12:30
i-80 Gold Provides Progress Update on its New Development Plan
RENO, Nev., July 8, 2025 /PRNewswire/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80" or the "Company") is pleased to provide an update on the progress of its new development plan...
07-08 19:15
超长周期 多元“玩法”——石家庄消费市场年中大促观察
从5月13日到6月20日，史上最长的一个“618”促销活动已经临近尾声。记者观察到，今年的年中大促不仅来得更早，“玩法”也更加多元。从5月中旬开始，线下各大商...
06-16 09:06
AnaptysBio Reports Positive Phase 2b Trial Results
An announcement from AnaptysBio ( ($ANAB) ) is now available. On June 3, 2025, ...
06-04 05:51
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
Renovaro Inc. subsidiary BioSymetrics receives a USPTO patent allowance for "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions." The patent enhances Renovaro's AI/ML IP portfolio by enabling integration and harmonization of diverse biomedical data sources into a standardized framework for predictive modeling. CEO David Weinstein highlights this as a strategic milestone, forming the foundation for an AI-powered drug ...
06-03 13:15
